-
JAMA
Viewpoint
April 8, 2024
Shirley V.ÌýWang,ÌýPhD; SebastianÌýSchneeweiss,ÌýMD, ScD
JAMA. 2024; 331(17):1445-1446. 10.1001/jama.2024.2988
This Viewpoint discusses the challenges involved with secondary health care data collection vs primary data collection and provides a list of suggested data checks before registration of a study protocol using secondary data.
-
JAMA Dermatology
Brief Report
January 31, 2024
Maria C.ÌýSchneeweiss,ÌýMD; DenysÌýShay,ÌýMD; SophiaÌýLy,ÌýBS; RichardÌýWyss; SebastianÌýSchneeweiss,ÌýMD, ScD; Robert J.ÌýGlynn,ÌýPhD, ScD; ArashÌýMostaghimi,ÌýMD, MPH
JAMA Dermatol. 2024; 160(3):334-340. 10.1001/jamadermatol.2023.5895
This descriptive analysis aims to determine the prevalence of pretreatment testing that is recommended for patients with chronic inflammatory skin diseases (psoriasis, hidradenitis suppurativa, or atopic dermatitis).
-
JAMA Internal Medicine
Comment & Response
February 12, 2024
SebastianÌýSchneeweiss,ÌýMD, ScD; Shirley V.ÌýWang,ÌýPhD
JAMA Intern Med. 2024; 184(4):446-446. 10.1001/jamainternmed.2023.7945
-
ÁñÁ«ÊÓƵ Network Open
Original Investigation
Statistics and Research Methods
September 27, 2023
Harrison J.ÌýHansford,ÌýBSc(Hons); Aidan G.ÌýCashin,ÌýPhD; Matthew D.ÌýJones,ÌýPhD; Sonja A.ÌýSwanson,ÌýScD; NazrulÌýIslam,ÌýMD, PhD; Susan R. G.ÌýDouglas,ÌýBExPhys; Rodrigo R. N.ÌýRizzo,ÌýPhD; Jack J.ÌýDevonshire,ÌýBSc(Hons); Sam A.ÌýWilliams,ÌýBSc(Hons); Issa J.ÌýDahabreh,ÌýMD, ScD; Barbra A.ÌýDickerman,ÌýPhD; MatthiasÌýEgger,ÌýMD, MSc; XabierÌýGarcia-Albeniz,ÌýMD, PhD; Robert M.ÌýGolub,ÌýMD; SaraÌýLodi,ÌýPhD; MargaritaÌýMoreno-Betancur,ÌýPhD; Sallie-AnneÌýPearson,ÌýPhD; SebastianÌýSchneeweiss,ÌýMD, ScD; Jonathan A. C.ÌýSterne,ÌýPhD; Melissa K.ÌýSharp,ÌýPhD; Elizabeth A.ÌýStuart,ÌýPhD; Miguel A.ÌýHernán,ÌýMD, DrPh; HopinÌýLee,ÌýPhD; James H.ÌýMcAuley,ÌýPhD
open access
ÁñÁ«ÊÓƵ Netw Open. 2023; 6(9):e2336023. 10.1001/jamanetworkopen.2023.36023
This systematic review assesses the reporting of observational studies that explicitly aimed to emulate target trials, hypothetical randomized trials that could answer causal questions of interest.
-
JAMA
Comment & Response
August 22, 2023
Shirley V.ÌýWang,ÌýPhD, ScM; SebastianÌýSchneeweiss,ÌýMD, ScD
JAMA. 2023; 330(8):770-771. 10.1001/jama.2023.11535
-
JAMA
Original Investigation
April 25, 2023
Shirley V.ÌýWang,ÌýPhD, ScM; SebastianÌýSchneeweiss,ÌýMD, ScD; RCT-DUPLICATE Initiative
free access
JAMA. 2023; 329(16):1376-1385. 10.1001/jama.2023.4221
This study uses results from randomized clinical trials as a reference to learn whether similar clinical conclusions could be drawn had the RCT protocol been translated and implemented as a database study protocol.
-
JAMA Dermatology
Original Investigation
February 8, 2023
Maria C.ÌýSchneeweiss,ÌýMD; Timothy J.ÌýSavage,ÌýMD, MPH; RichardÌýWyss,ÌýPhD; YinzhuÌýJin,ÌýMPH; KatharinaÌýSchoder,ÌýMSc; Joseph F.ÌýMerola,ÌýMD, MMSc; RobertÌýSidbury,ÌýMD, MPH; TheresaÌýOduol,ÌýBS; SebastianÌýSchneeweiss,ÌýMD, ScD; Robert J.ÌýGlynn,ÌýPhD, ScD
free access
JAMA Dermatol. 2023; 159(3):289-298. 10.1001/jamadermatol.2022.6325
This cohort study uses insurance claims data to estimate the 6-month rate of infections among children with psoriasis who started treatment with ustekinumab, etanercept, or methotrexate.
-
ÁñÁ«ÊÓƵ Network Open
Original Investigation
Diabetes and Endocrinology
October 20, 2022
Phyo T.ÌýHtoo,ÌýMD, PhD; HelenÌýTesfaye,ÌýPharmD, MSc; SebastianÌýSchneeweiss,ÌýMD, ScD; Deborah J.ÌýWexler,ÌýMD, MSc; Brendan M.ÌýEverett,ÌýMD; Robert J.ÌýGlynn,ÌýScD, PhD; Seoyoung C.ÌýKim,ÌýMD, ScD; MehdiÌýNajafzadeh,ÌýPhD; LisetteÌýKoeneman,ÌýMD; Soulmaz FazeliÌýFarsani,ÌýPharmD, MSc, PhD; AnoukÌýDéruaz-Luyet,ÌýPhD, MPH; Julie M.ÌýPaik,ÌýMD, ScD; ElisabettaÌýPatorno,ÌýMD, DrPH
open access
ÁñÁ«ÊÓƵ Netw Open. 2022; 5(10):e2237606. 10.1001/jamanetworkopen.2022.37606
This comparative effectiveness study evaluates the association of empagliflozin with cardiovascular outcomes compared with liraglutide and sitagliptin among older adults with type 2 diabetes and diverse characteristics.
-
ÁñÁ«ÊÓƵ Network Open
Original Investigation
Neurology
April 8, 2022
Rishi J.ÌýDesai,ÌýPhD; Vijay R.ÌýVarma,ÌýPhD; TobiasÌýGerhard,ÌýPhD; JodiÌýSegal,ÌýMD, MPH; MufaddalÌýMahesri,ÌýMD, MPH; KristynÌýChin,ÌýBS; Daniel B.ÌýHorton,ÌýMD, MSCE; Seoyoung C.ÌýKim,ÌýMD, ScD; SebastianÌýSchneeweiss,ÌýMD, ScD; MadhavÌýThambisetty,ÌýMD, PhD
open access
ÁñÁ«ÊÓƵ Netw Open. 2022; 5(4):e226567. 10.1001/jamanetworkopen.2022.6567
This cohort study compares incidence of Alzheimer disease and related dementia among Medicare patients with rheumatoid arthritis using disease-modifying antirheumatic drugs.
-
ÁñÁ«ÊÓƵ Network Open
Original Investigation
Infectious Diseases
March 17, 2022
Jennifer M.ÌýPolinski,ÌýScD, MPH, MSc; Andrew R.ÌýWeckstein,ÌýBA; MichaelÌýBatech,ÌýDrPH; CarlyÌýKabelac,ÌýBS; TripthiÌýKamath,ÌýPhD; RaymondÌýHarvey,ÌýMPH; SidÌýJain,ÌýBS; Jeremy A.ÌýRassen,ÌýScD; NajatÌýKhan,ÌýPhD; SebastianÌýSchneeweiss,ÌýMD, ScD
open access
is active quiz
ÁñÁ«ÊÓƵ Netw Open. 2022; 5(3):e222959. 10.1001/jamanetworkopen.2022.2959
This cohort study assesses the association between receiving the Ad26.COV2.S vaccine and COVID-19–related infections and hospitalizations before and during the Delta variant surge.
-
JAMA Dermatology
Original Investigation
May 26, 2021
Maria C.ÌýSchneeweiss,ÌýMD; Seoyoung C.ÌýKim,ÌýMD, ScD; RichardÌýWyss,ÌýPhD; YinzhuÌýJin,ÌýMD; KristynÌýChin,ÌýBS; Joseph F.ÌýMerola,ÌýMD, MMSc; ArashÌýMostaghimi,ÌýMD, MPA, MPH; Jonathan I.ÌýSilverberg,ÌýMD, PhD, MPH; SebastianÌýSchneeweiss,ÌýMD, ScD
free access
JAMA Dermatol. 2021; 157(7):805-816. 10.1001/jamadermatol.2021.1570
This cohort study examines the incidence of venous thromboembolism in patients with chronic inflammatory skin diseases.
-
JAMA Dermatology
Research Letter
January 22, 2020
Maria C.ÌýSchneeweiss,ÌýMD; Seoyoung C.ÌýKim,ÌýMD, ScD; SebastianÌýSchneeweiss,ÌýMD, ScD; DavidÌýRosmarin,ÌýMD; Joseph F.ÌýMerola,ÌýMD, MMSc
free access
JAMA Dermatol. 2020; 156(3):342-345. 10.1001/jamadermatol.2019.4590
This cohort study evaluates the risk of developing inflammatory arthritis among patients with hidradenitis suppurativa.
-
ÁñÁ«ÊÓƵ Network Open
Original Investigation
Cardiology
January 10, 2020
Rishi J.ÌýDesai,ÌýMS, PhD; Shirley V.ÌýWang,ÌýPhD; MuthiahÌýVaduganathan,ÌýMD, MPH; ThomasÌýEvers,ÌýPhD; SebastianÌýSchneeweiss,ÌýMD, ScD
open access
ÁñÁ«ÊÓƵ Netw Open. 2020; 3(1):e1918962. 10.1001/jamanetworkopen.2019.18962
This prognostic study compares several machine learning approaches with traditional logistic regression for development of predictive models for all-cause mortality, heart failure hospitalization, high cost, and loss in home time, among patients with heart failure.
-
JAMA Internal Medicine
Research Letter
September 3, 2019
Chintan V.ÌýDave,ÌýPharmD, PhD; SebastianÌýSchneeweiss,ÌýMD, ScD; ElisabettaÌýPatorno,ÌýMD, DrPH
free access
JAMA Intern Med. 2019; 179(11):1587-1590. 10.1001/jamainternmed.2019.2813
This cohort study assesses the association between initiation of sodium-glucose cotransporter 2 (SGLT-2) inhibitor treatment and the risk of hospitalization for Fournier gangrene among men.
-
JAMA Internal Medicine
Original Investigation
May 6, 2019
JuliaÌýSpoendlin,ÌýPhD, MPH; Julie M.ÌýPaik,ÌýMD, ScD; T.ÌýTsacogianis,ÌýMPH; Seoyoung C.ÌýKim,ÌýMD, ScD; SebastianÌýSchneeweiss,ÌýMD, ScD; Rishi J.ÌýDesai,ÌýMS, PhD
free access
JAMA Intern Med. 2019; 179(6):741-749. 10.1001/jamainternmed.2019.0045
This observational study examines the use of sevelamer vs calcium acetate for treatment of hyperphosphatemia in patients 65 years or older with end-stage renal disease who are undergoing hemodialysis.
-
JAMA Internal Medicine
Original Investigation
January 1, 2018
MichaelÌýFralick,ÌýMD; Aaron S.ÌýKesselheim,ÌýMD, JD, MPH; JerryÌýAvorn,ÌýMD; SebastianÌýSchneeweiss,ÌýMD, ScD
open access
JAMA Intern Med. 2018; 178(1):55-63. 10.1001/jamainternmed.2017.3919
This study examines whether longitudinal data from a health care database can support the results of a randomized clinical trial that led to a supplemental indication of telmisartan.
-
JAMA
Comment & Response
July 11, 2017
Steven N.ÌýGoodman,ÌýMD, MHS, PhD; SebastianÌýSchneeweiss,ÌýMD, ScD
JAMA. 2017; 318(2):201-202. 10.1001/jama.2017.6235
-
JAMA
Editorial
February 21, 2017
Steven N.ÌýGoodman,ÌýMD, MHS, PhD; SebastianÌýSchneeweiss,ÌýMD, ScD; MichaelÌýBaiocchi,ÌýPhD
JAMA. 2017; 317(7):705-707. 10.1001/jama.2016.19970
-
JAMA Internal Medicine
Editor's Correspondence
August 8, 2011
Daniel H. Solomon, MD, MPH; Jeremy Rassen, PhD; Robert J. Glynn, PhD, ScD; Raisa Levin, MSc; Sebastian Schneeweiss, MD, ScD
Arch Intern Med. 2011; 171(15):1401-1404. 10.1001/archinternmed.2011.344
-
JAMA Internal Medicine
Editor's Correspondence
June 27, 2011
Daniel H. Solomon, MD, MPH; Jeremy A. Rassen, ScD; Robert J. Glynn, PhD; Sebastian Schneeweiss, MD, ScD
Arch Intern Med. 2011; 171(12):1127-1127. 10.1001/archinternmed.2011.263